HAOXI HEALTH TECHNOLOGY LIMITED
Last · NASDAQ$2.16-0.11 (-4.85%)close · yahoo · 14h ago
Market cap$790832.00350.2K sh
P/E · TTM-0.0fwd — · eps -386.40 · loss
Beta-1.08vs S&P 500
Div yield0.00%annual · TTM
52w range
$2.10$4352.00
Volume54.4Ksession
| Revenue | $54.8M |
|---|---|
| Operating income | $-9.7M |
| Net income | $-9.5M |
| Free cash flow | $-2.6M |
| Operating margin | -17.6% |
| Net margin | -17.4% |
| Return on equity | -53.4% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 20-F · 2026-09-30
- Credit Loss Surge
- Supplier Concentration
- Digital Asset Impairment
- Equity Dilution
- Related Party Governance
- China Concentration
Red flags
- Customer credit quality deteriorated sharply: the doubtful-account allowance rose to $4.593 million, and two customers represented 23% and 22% of accounts receivable.
- Supplier dependence is extreme: one supplier accounted for 99.41% of FY2026 purchases and 99.17% of accounts payable, creating disruption and bargaining-power risk.
- Governance and dilution risks are material: Class B shares carry 30 votes each, a shareholder received a $1 million interest-free loan during the year, shareholders received $800,000 of bonuses, and the company issued substantial equity and prefunded warrants.
- Tax payable was $1.237 million at year-end, while the company reported a $9.536 million net loss and recorded a full valuation allowance against $143,771 of deferred tax assets.
Earnings transcripts
Press & signals
- GlobeNewswire
Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split
- GlobeNewswire
Haoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing System
- GlobeNewswire
Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering
Documents
FormReporting forFiledFlags